StonvexLoading…
StonvexStonvexStonvexCore line items from CGNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $400.04M | $350.63M | $313.40M | $312.06M |
Operating Income | $13.26M | $-5.13M | $-18.05M | $-103.32M |
Net Income | $-638.00K | $-12.05M | $-15.57M | $-114.13M |
EPS (Diluted) | $-0.01 | $-0.17 | $-0.22 | $-1.68 |
Total Assets | $521.07M | $497.82M | $472.08M | $443.08M |
Total Liabilities | $292.20M | $280.72M | $257.35M | $233.30M |
Cash & Equivalents | $116.88M | $112.72M | $74.48M | $34.58M |
Free Cash Flow OCF − CapEx | $29.93M | $36.20M | $27.53M | $-45.26M |
Shares Outstanding | 73.08M | 72.06M | 71.00M | 68.84M |